INBS Relative Valuation
INBS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, INBS is overvalued; if below, it's undervalued.
Historical Valuation
Intelligent Bio Solutions Inc (INBS) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.28 is considered Undervalued compared with the five-year average of -1.38. The fair price of Intelligent Bio Solutions Inc (INBS) is between 18.26 to 40.75 according to relative valuation methord. Compared to the current price of 14.31 USD , Intelligent Bio Solutions Inc is Undervalued By 21.61%.
Relative Value
Fair Zone
18.26-40.75
Current Price：14.31
21.61%
Undervalued
2.25
PE
1Y
3Y
5Y
0.00
EV/EBITDA
Intelligent Bio Solutions Inc. (INBS) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
3.67
EV/EBIT
Intelligent Bio Solutions Inc. (INBS) has a current EV/EBIT of 3.67. The 5-year average EV/EBIT is -0.10. The thresholds are as follows: Strongly Undervalued below -3.58, Undervalued between -3.58 and -1.84, Fairly Valued between 1.64 and -1.84, Overvalued between 1.64 and 3.38, and Strongly Overvalued above 3.38. The current Forward EV/EBIT of 3.67 falls within the Strongly Overvalued range.
0.28
PS
Intelligent Bio Solutions Inc. (INBS) has a current PS of 0.28. The 5-year average PS is 15.00. The thresholds are as follows: Strongly Undervalued below -53.70, Undervalued between -53.70 and -19.35, Fairly Valued between 49.35 and -19.35, Overvalued between 49.35 and 83.71, and Strongly Overvalued above 83.71. The current Forward PS of 0.28 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Intelligent Bio Solutions Inc. (INBS) has a current P/OCF of 0.00. The 5-year average P/OCF is -2.11. The thresholds are as follows: Strongly Undervalued below -8.03, Undervalued between -8.03 and -5.07, Fairly Valued between 0.84 and -5.07, Overvalued between 0.84 and 3.80, and Strongly Overvalued above 3.80. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Intelligent Bio Solutions Inc. (INBS) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Intelligent Bio Solutions Inc (INBS) has a current Price-to-Book (P/B) ratio of 1.98. Compared to its 3-year average P/B ratio of 1.40 , the current P/B ratio is approximately 41.48% higher. Relative to its 5-year average P/B ratio of 1.69, the current P/B ratio is about 17.55% higher. Intelligent Bio Solutions Inc (INBS) has a Forward Free Cash Flow (FCF) yield of approximately -139.97%. Compared to its 3-year average FCF yield of -163.18%, the current FCF yield is approximately -14.23% lower. Relative to its 5-year average FCF yield of -114.65% , the current FCF yield is about 22.08% lower.
1.98
P/B
Median3y
1.40
Median5y
1.69
-139.97
FCF Yield
Median3y
-163.18
Median5y
-114.65
Competitors Valuation Multiple
The average P/S ratio for INBS's competitors is 0.42, providing a benchmark for relative valuation. Intelligent Bio Solutions Inc Corp (INBS) exhibits a P/S ratio of 0.28, which is -31.96% above the industry average. Given its robust revenue growth of 27.46%, this premium appears sustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of INBS decreased by 32.73% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 872.29K to 1.11M.
The secondary factor is the Margin Expansion, contributed -12.80%to the performance.
Overall, the performance of INBS in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
Frequently Asked Questions
Is Intelligent Bio Solutions Inc (INBS) currently overvalued or undervalued?
Intelligent Bio Solutions Inc (INBS) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.28 is considered Undervalued compared with the five-year average of -1.38. The fair price of Intelligent Bio Solutions Inc (INBS) is between 18.26 to 40.75 according to relative valuation methord. Compared to the current price of 14.31 USD , Intelligent Bio Solutions Inc is Undervalued By 21.61% .
What is Intelligent Bio Solutions Inc (INBS) fair value?
INBS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Intelligent Bio Solutions Inc (INBS) is between 18.26 to 40.75 according to relative valuation methord.
How does INBS's valuation metrics compare to the industry average?
The average P/S ratio for INBS's competitors is 0.42, providing a benchmark for relative valuation. Intelligent Bio Solutions Inc Corp (INBS) exhibits a P/S ratio of 0.28, which is -31.96% above the industry average. Given its robust revenue growth of 27.46%, this premium appears sustainable.
What is the current P/B ratio for Intelligent Bio Solutions Inc (INBS) as of Jan 08 2026?
As of Jan 08 2026, Intelligent Bio Solutions Inc (INBS) has a P/B ratio of 1.98. This indicates that the market values INBS at 1.98 times its book value.
What is the current FCF Yield for Intelligent Bio Solutions Inc (INBS) as of Jan 08 2026?
As of Jan 08 2026, Intelligent Bio Solutions Inc (INBS) has a FCF Yield of -139.97%. This means that for every dollar of Intelligent Bio Solutions Inc’s market capitalization, the company generates -139.97 cents in free cash flow.
What is the current Forward P/E ratio for Intelligent Bio Solutions Inc (INBS) as of Jan 08 2026?
As of Jan 08 2026, Intelligent Bio Solutions Inc (INBS) has a Forward P/E ratio of 2.25. This means the market is willing to pay $2.25 for every dollar of Intelligent Bio Solutions Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Intelligent Bio Solutions Inc (INBS) as of Jan 08 2026?
As of Jan 08 2026, Intelligent Bio Solutions Inc (INBS) has a Forward P/S ratio of 0.28. This means the market is valuing INBS at $0.28 for every dollar of expected revenue over the next 12 months.